Objective
To estimate the risk of adverse perinatal outcomes among women with isolated fetal growth restriction from 17 to 22 weeks of gestation.
Methods
This was a retrospective cohort study of all singleton, non-anomalous pregnancies undergoing ultrasound to assess fetal anatomy between 17 and 22 weeks of gestation at a single center from 2010 to 2014. After excluding patients with fetal structural malformations, chromosomal abnormalities, or identified infection etiologies, we compared perinatal outcomes between pregnancies with and without fetal growth restriction, defined as estimated fetal weight <10th percentile for gestational age. Our primary outcome was small for gestational age (SGA) at birth, defined as birthweight < 10th percentile. Secondary outcomes included preterm delivery <37 weeks and <28 weeks, preeclampsia, abruption, stillbirth, neonatal death, neonatal intensive care unit (NICU) admission, intraventricular hemorrhage, need for respiratory support, and necrotizing enterocolitis.
Results
Of 12,783 eligible patients, 355 (2.8%) had early second-trimester fetal growth restriction. Risk factors for growth restriction were African American race and tobacco use. Early second-trimester growth restriction was associated with over a fivefold increase in risk of SGA at birth (36.9% vs 9.1%, aOR 5.5, 95% CI 4.3, 7.0), stillbirth (2.5% vs 0.4%, OR 6.2, 95% CI 2.7, 12.8), and neonatal death (1.4% vs 0.3%, OR 5.2, 95% CI 1.6, 13.5). Rates of indicated preterm birth <37 weeks (7.3% vs 3.3%, OR 2.3, 95% CI 1.5,3.5) and <28 weeks (2.5% vs 0.2%, OR 10.8, 95% CI 4.5,23.4), neonatal need for respiratory support (16.9% vs 7.8%, aOR 1.6, 95% CI 1.1,2.2), and necrotizing enterocolitis (1.4% vs 0.2%, OR 7.7, 95% CI 2.3, 20.9) were also significantly higher for those with growth restriction. Rates of preeclampsia, abruption, and other neonatal outcomes were not significantly different.
Conclusion
Although fetal growth restriction in the early second trimester occurred in less than 3% of our cohort and most of those with isolated growth restriction did not have adverse outcomes, it is a strong risk factor for SGA, stillbirth, neonatal death, and indicated preterm birth.